![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-desktop-header-1gif-4289.gif)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-mobgif-81230.gif)
X
20
Kern Pharma, S.l. Terrassa Es, based in Spain, is a pharmaceutical company.
One of their significant offerings is Remifentanil hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2017-065 - Rev 00
This Chemical Type CEP, issued on January 20, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2644 associated with this CEP further emphasizes